BIONOMICS LIMITED - AM

Bionomics to Present at the 2024 CNS Summit

07 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire

Bionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology Program

04 ноя 2024 16:15:00 Источник Nasdaq GlobeNewswire

Bionomics to Present at the ThinkEquity Conference

23 окт 2024 06:00:00 Источник Nasdaq GlobeNewswire

Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC

14 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

Bionomics Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

07 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

Bionomics Limited announces intention to re-domicile to the United States

01 окт 2024 06:30:00 Источник Nasdaq GlobeNewswire

Bionomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03 сен 2024 06:30:00 Источник Nasdaq GlobeNewswire

Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder

31 июл 2024 06:30:00 Источник Nasdaq GlobeNewswire

Bionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024

29 июл 2024 16:30:00 Источник Nasdaq GlobeNewswire

Bionomics Initiates AFFIRM-1, a Phase 3 Clinical Trial with BNC210 for Social Anxiety Disorder

18 июл 2024 06:30:00 Источник Nasdaq GlobeNewswire

Bionomics Limited Announces Private Placement of up to $70.0 Million

31 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting

20 май 2024 06:30:00 Источник Nasdaq GlobeNewswire

Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder

21 мар 2024 06:00:00 Источник Nasdaq GlobeNewswire

Bionomics to Present at the 2024 BIO CEO & Investor Conference

22 фев 2024 16:30:00 Источник Nasdaq GlobeNewswire

Bionomics Provides a Review of 2023 and of 2024 Plans

22 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire

Bionomics to Present at Biotech Showcase™ 2024

05 янв 2024 06:00:00 Источник Nasdaq GlobeNewswire

Bionomics Presents Detailed Data on the Validity and Reliability of the Subjective Units of Distress Scale at the 2023 American College of Neuropsychopharmacology Annual Meeting

06 дек 2023 08:00:00 Источник Nasdaq GlobeNewswire

Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA and Solidifies Plans to Initiate the Registrational Program for BNC210 in Social Anxiety Disorder

16 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire

Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)

28 сен 2023 06:00:52 Источник Nasdaq GlobeNewswire

Bionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSD

14 сен 2023 06:00:00 Источник Nasdaq GlobeNewswire